Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s12943-023-01751-9.

Title:
New frontiers in immune checkpoint B7-H3 (CD276) research and drug development | Molecular Cancer
Description:
B7-H3 (CD276), a member of the B7 family of proteins, is a key player in cancer progression. This immune checkpoint molecule is selectively expressed in both tumor cells and immune cells within the tumor microenvironment. In addition to its immune checkpoint function, B7-H3 has been linked to tumor cell proliferation, metastasis, and therapeutic resistance. Furthermore, its drastic difference in protein expression levels between normal and tumor tissues suggests that targeting B7-H3 with drugs would lead to cancer-specific toxicity, minimizing harm to healthy cells. These properties make B7-H3 a promising target for cancer therapy. Recently, important advances in B7-H3 research and drug development have been reported, and these new findings, including its involvement in cellular metabolic reprograming, cancer stem cell enrichment, senescence and obesity, have expanded our knowledge and understanding of this molecule, which is important in guiding future strategies for targeting B7-H3. In this review, we briefly discuss the biology and function of B7-H3 in cancer development. We emphasize more on the latest findings and their underlying mechanisms to reflect the new advances in B7-H3 research. In addition, we discuss the new improvements of B-H3 inhibitors in cancer drug development.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

cancer, pubmed, cells, article, scholar, google, cas, cell, expression, central, tumor, immune, wang, protein, human, zhang, expressed, senescence, tissues, stem, targeting, pathway, role, res, yang, development, studies, promotes, drug, therapy, receptor, carcinoma, liu, chen, checkpoint, normal, target, immunol, research, family, resistance, breast, study, reported, cellular, showed, including, clinical, treatment, pdl,

Topics {✒️}

sirt1/nf-kappab/b7-h3/tnf-alpha axis sirt1/nf‑κb/b7‑h3/tnf‑α axis [73] ccl2-ccr2-m2 macrophage axis jak1-stat3-sox2 signaling pathway b7h4-dependent anti-tumor immunity pi3k/akt/stat3 signaling pathway pi3k/akt/bcl-2 signaling pathway cell-dependent anti-tumor immunity low-dose doxorubicin-induced senescence tlr4/nf-κb pathway akt/tm4sf1/sirt1 pathway b7-h3 localization profiles fut8-mediated aberrant n-glycosylation crispr/cas9 mediated knockout anti-b7-h3 therapeutic agents b7-h3 post-translational modifications pi3k/akt/mtor signaling b7-h3 research b7-h3 neck squamous-cell carcinoma pi3k/akt signaling pathway immune receptors b7–h3/cd276 pi3k/akt/mtor pathway [91] pi3k/akt/mtor pathway mir‑34a induces immunosuppression mir-34a induces immunosuppression b-h3 inhibitors interferon-dependent ido induction b7-h3 targeted rit nk cell-mediated cytotoxicity full size image ifn-gamma-dependent cytotoxicity nf-κb pathway [79] nf-κb pathway nfat-dependent il-6 release pi3k/akt/mtor signalling b7-h3-induced signaling wnt/β-catenin pathway article download pdf anti-b7-h3 approaches special expression profile b7-h3 enhanced glycolysis successful targeting b7-h3 b7-h3 dramatically increased rhabdomyosarcoma reveals b7-h3 b7-h3 positively correlated abrogating jak2/stat3 phosphorylation mvp-mediated mek activation b7-h3 protein stability anti-tumor immune responses costimulatory human b7-h3

Questions {❓}

  • The immune checkpoint inhibitors: where are we now?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:New frontiers in immune checkpoint B7-H3 (CD276) research and drug development
         description:B7-H3 (CD276), a member of the B7 family of proteins, is a key player in cancer progression. This immune checkpoint molecule is selectively expressed in both tumor cells and immune cells within the tumor microenvironment. In addition to its immune checkpoint function, B7-H3 has been linked to tumor cell proliferation, metastasis, and therapeutic resistance. Furthermore, its drastic difference in protein expression levels between normal and tumor tissues suggests that targeting B7-H3 with drugs would lead to cancer-specific toxicity, minimizing harm to healthy cells. These properties make B7-H3 a promising target for cancer therapy. Recently, important advances in B7-H3 research and drug development have been reported, and these new findings, including its involvement in cellular metabolic reprograming, cancer stem cell enrichment, senescence and obesity, have expanded our knowledge and understanding of this molecule, which is important in guiding future strategies for targeting B7-H3. In this review, we briefly discuss the biology and function of B7-H3 in cancer development. We emphasize more on the latest findings and their underlying mechanisms to reflect the new advances in B7-H3 research. In addition, we discuss the new improvements of B-H3 inhibitors in cancer drug development.
         datePublished:2023-03-02T00:00:00Z
         dateModified:2023-03-02T00:00:00Z
         pageStart:1
         pageEnd:15
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12943-023-01751-9
         keywords:
            B7-H3
            CD276
            Cancer
            Immunotherapy
            Drug Development
            Cancer Research
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-023-01751-9/MediaObjects/12943_2023_1751_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-023-01751-9/MediaObjects/12943_2023_1751_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-023-01751-9/MediaObjects/12943_2023_1751_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-023-01751-9/MediaObjects/12943_2023_1751_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-023-01751-9/MediaObjects/12943_2023_1751_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-023-01751-9/MediaObjects/12943_2023_1751_Fig6_HTML.png
         isPartOf:
            name:Molecular Cancer
            issn:
               1476-4598
            volumeNumber:22
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Ayechew Adera Getu
               affiliation:
                     name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University
                     address:
                        name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University, Taichung, Taiwan
                        type:PostalAddress
                     type:Organization
                     name:University of Gondar
                     address:
                        name:Department of Physiology, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Abiye Tigabu
               affiliation:
                     name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University
                     address:
                        name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University, Taichung, Taiwan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ming Zhou
               affiliation:
                     name:Cancer Research Institute and School of Basic Medical Sciences, Central South University
                     address:
                        name:Cancer Research Institute and School of Basic Medical Sciences, Central South University, Changsha, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jianrong Lu
               affiliation:
                     name:University of Florida
                     address:
                        name:Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Øystein Fodstad
               affiliation:
                     name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
                     address:
                        name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ming Tan
               affiliation:
                     name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University
                     address:
                        name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University, Taichung, Taiwan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:New frontiers in immune checkpoint B7-H3 (CD276) research and drug development
      description:B7-H3 (CD276), a member of the B7 family of proteins, is a key player in cancer progression. This immune checkpoint molecule is selectively expressed in both tumor cells and immune cells within the tumor microenvironment. In addition to its immune checkpoint function, B7-H3 has been linked to tumor cell proliferation, metastasis, and therapeutic resistance. Furthermore, its drastic difference in protein expression levels between normal and tumor tissues suggests that targeting B7-H3 with drugs would lead to cancer-specific toxicity, minimizing harm to healthy cells. These properties make B7-H3 a promising target for cancer therapy. Recently, important advances in B7-H3 research and drug development have been reported, and these new findings, including its involvement in cellular metabolic reprograming, cancer stem cell enrichment, senescence and obesity, have expanded our knowledge and understanding of this molecule, which is important in guiding future strategies for targeting B7-H3. In this review, we briefly discuss the biology and function of B7-H3 in cancer development. We emphasize more on the latest findings and their underlying mechanisms to reflect the new advances in B7-H3 research. In addition, we discuss the new improvements of B-H3 inhibitors in cancer drug development.
      datePublished:2023-03-02T00:00:00Z
      dateModified:2023-03-02T00:00:00Z
      pageStart:1
      pageEnd:15
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12943-023-01751-9
      keywords:
         B7-H3
         CD276
         Cancer
         Immunotherapy
         Drug Development
         Cancer Research
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-023-01751-9/MediaObjects/12943_2023_1751_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-023-01751-9/MediaObjects/12943_2023_1751_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-023-01751-9/MediaObjects/12943_2023_1751_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-023-01751-9/MediaObjects/12943_2023_1751_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-023-01751-9/MediaObjects/12943_2023_1751_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-023-01751-9/MediaObjects/12943_2023_1751_Fig6_HTML.png
      isPartOf:
         name:Molecular Cancer
         issn:
            1476-4598
         volumeNumber:22
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Ayechew Adera Getu
            affiliation:
                  name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University
                  address:
                     name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University, Taichung, Taiwan
                     type:PostalAddress
                  type:Organization
                  name:University of Gondar
                  address:
                     name:Department of Physiology, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Abiye Tigabu
            affiliation:
                  name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University
                  address:
                     name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University, Taichung, Taiwan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ming Zhou
            affiliation:
                  name:Cancer Research Institute and School of Basic Medical Sciences, Central South University
                  address:
                     name:Cancer Research Institute and School of Basic Medical Sciences, Central South University, Changsha, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jianrong Lu
            affiliation:
                  name:University of Florida
                  address:
                     name:Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Øystein Fodstad
            affiliation:
                  name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
                  address:
                     name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ming Tan
            affiliation:
                  name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University
                  address:
                     name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University, Taichung, Taiwan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Molecular Cancer
      issn:
         1476-4598
      volumeNumber:22
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University
      address:
         name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University, Taichung, Taiwan
         type:PostalAddress
      name:University of Gondar
      address:
         name:Department of Physiology, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia
         type:PostalAddress
      name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University
      address:
         name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University, Taichung, Taiwan
         type:PostalAddress
      name:Cancer Research Institute and School of Basic Medical Sciences, Central South University
      address:
         name:Cancer Research Institute and School of Basic Medical Sciences, Central South University, Changsha, China
         type:PostalAddress
      name:University of Florida
      address:
         name:Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, USA
         type:PostalAddress
      name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
      address:
         name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
         type:PostalAddress
      name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University
      address:
         name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University, Taichung, Taiwan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Ayechew Adera Getu
      affiliation:
            name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University
            address:
               name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University, Taichung, Taiwan
               type:PostalAddress
            type:Organization
            name:University of Gondar
            address:
               name:Department of Physiology, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia
               type:PostalAddress
            type:Organization
      name:Abiye Tigabu
      affiliation:
            name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University
            address:
               name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University, Taichung, Taiwan
               type:PostalAddress
            type:Organization
      name:Ming Zhou
      affiliation:
            name:Cancer Research Institute and School of Basic Medical Sciences, Central South University
            address:
               name:Cancer Research Institute and School of Basic Medical Sciences, Central South University, Changsha, China
               type:PostalAddress
            type:Organization
      name:Jianrong Lu
      affiliation:
            name:University of Florida
            address:
               name:Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, USA
               type:PostalAddress
            type:Organization
      name:Øystein Fodstad
      affiliation:
            name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet
            address:
               name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
               type:PostalAddress
            type:Organization
      name:Ming Tan
      affiliation:
            name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University
            address:
               name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University, Taichung, Taiwan
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University, Taichung, Taiwan
      name:Department of Physiology, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia
      name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University, Taichung, Taiwan
      name:Cancer Research Institute and School of Basic Medical Sciences, Central South University, Changsha, China
      name:Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, USA
      name:Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway
      name:Institute of Biochemistry and Molecular Biology, Institute of Biomedical Sciences, and Research Center for Cancer Biology, China Medical University, Taichung, Taiwan

External Links {🔗}(472)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.92s.